BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11834627)

  • 1. Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase.
    Suenaga H; Kamata K
    Br J Pharmacol; 2002 Feb; 135(3):789-99. PubMed ID: 11834627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine activates extracellular-signal-regulated protein kinase and potentiates vascular contractile responses in rat aorta.
    Suenaga H; Kamata K
    J Pharmacol Sci; 2003 Aug; 92(4):348-58. PubMed ID: 12939519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.
    Matsumoto T; Kobayashi T; Kamata K
    Br J Pharmacol; 2006 Dec; 149(7):931-41. PubMed ID: 17031383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity.
    Petrescu G; Costuleanu M; Slatineanu SM; Costuleanu N; Foia L; Costuleanu A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):180-7. PubMed ID: 11881120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylcholine potentiates vascular contractile responses by enhancing vasoconstrictor-induced increase in cytosolic free Ca2+ in rat aorta.
    Suenaga H; Kamata K
    Eur J Pharmacol; 1998 Nov; 361(2-3):217-26. PubMed ID: 9865511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta.
    Jinsi A; Paradise J; Deth RC
    Eur J Pharmacol; 1996 Apr; 302(1-3):183-90. PubMed ID: 8791006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase.
    Watts SW; Yeum CH; Campbell G; Webb RC
    J Vasc Res; 1996; 33(4):288-98. PubMed ID: 8695753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct effect of levobupivacaine in isolated rat aorta involves lipoxygenase pathway activation and endothelial nitric oxide release.
    Choi YS; Jeong YS; Ok SH; Shin IW; Lee SH; Park JY; Hwang EM; Hah YS; Sohn JT
    Anesth Analg; 2010 Feb; 110(2):341-9. PubMed ID: 19955508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle.
    Abebe W; Agrawal DK
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):153-9. PubMed ID: 7564357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-adrenoceptor agonists produce Ca2+ oscillations in isolated rat aorta: role of protein kinase C.
    Suenaga H; Kamata K
    J Smooth Muscle Res; 2000 Dec; 36(6):205-18. PubMed ID: 11398898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of vascular and gastric smooth muscle contractility by pervanadate.
    Laniyonu A; Saifeddine M; Ahmad S; Hollenberg MD
    Br J Pharmacol; 1994 Oct; 113(2):403-10. PubMed ID: 7530569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction.
    Yu J; Mizumoto K; Kakutani T; Hasegawa A; Ogawa K; Hatano Y
    Acta Anaesthesiol Scand; 2005 Jul; 49(6):852-8. PubMed ID: 15954971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinases participate in alpha 1A-adrenoceptor-mediated vasoconstriction in perfused rat hindlimb.
    Zhu WZ; Han QD
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):473-7. PubMed ID: 10375814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
    Sauro MD; Thomas B
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase.
    Duarte J; Ocete MA; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
    Eur J Pharmacol; 1997 Oct; 338(1):25-33. PubMed ID: 9408000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine potentiates phenylephrine responses in rat mesenteric arterial bed through modulation of thromboxane A2.
    Zhang R; Rodrigues B; MacLeod KM
    J Pharmacol Exp Ther; 2006 Apr; 317(1):355-61. PubMed ID: 16394197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of genistein on ATP-sensitive K+ channels in rabbit portal vein smooth muscle.
    Ogata R; Kitamura K; Ito Y; Nakano H
    Br J Pharmacol; 1997 Dec; 122(7):1395-404. PubMed ID: 9421287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dual-action genistein derivatives on relaxation in rat aorta.
    Matsumoto T; Kobayashi T; Kikuchi T; Honda T; Kamata K
    J Smooth Muscle Res; 2005 Feb; 41(1):23-33. PubMed ID: 15855737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.
    Rossowski WJ; Cheng BL; Taylor JE; Datta R; Coy DH
    Eur J Pharmacol; 2002 Mar; 438(3):159-70. PubMed ID: 11909607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.